- Filed
- Apr 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Apr 8, 2025 | 16.09M sh |
| Shares Diluted | FY 2025 · Jan 31, 2024 | 16.39M sh |
| Stock Repurchased restated | FY 2025 · Jan 31, 2024 | $0 |
| Capex | FY 2025 · Jan 31, 2024 | $5.25M |
| Operating Cash Flow | FY 2025 · Jan 31, 2024 | $26.96M |
| Long Term Debt | FY 2025 · Jan 31, 2024 | $4.14M |
| Short Term Debt | FY 2025 · Jan 31, 2024 | $248K |
| Current Liabilities | FY 2025 · Jan 31, 2024 | $38.53M |
| Current Assets | FY 2025 · Jan 31, 2024 | $89.03M |
| Total Assets | FY 2025 · Jan 31, 2024 | $146.45M |
| Eps Diluted | FY 2025 · Jan 31, 2024 | $1.34 |
| Eps Basic | FY 2025 · Jan 31, 2024 | $1.34 |
| Sga Expense | FY 2025 · Jan 31, 2024 | $84.18M |
| Net Income | FY 2025 · Jan 31, 2024 | $21.91M |
| Operating Income | FY 2025 · Jan 31, 2024 | $31.88M |
| Gross Profit | FY 2025 · Jan 31, 2024 | $116.06M |
| Revenue | FY 2025 · Jan 31, 2024 | $269.12M |
| Stockholders Equity | FY 2025 · Jan 31, 2023 | $68.06M |